OGN Organon & Co. Insider Trading

SVP and Corporate Controller Lynette Holzbaur doubles her stake in OGN with substantial open-market purchase near 52-week highs.

Lynette Holzbaur, SVP and Corporate Controller at Organon, deployed over $350,000 to roughly double her shareholding, a significant personal investment that signals conviction in the company's direction. Her purchase comes as the stock is trading at its highest point in the past year after a sustained rally, which is noteworthy because most insider buying occurs during pullbacks or weakness—buying at peaks carries added credibility. Organon remains profitable with solid quarterly earnings, though annual revenue is facing modest headwinds; Holzbaur's timing suggests she sees value despite the near-term revenue pressure and elevated valuation. As a C-suite officer with direct operational visibility, her willingness to substantially increase her personal ownership at these levels speaks to confidence in management's ability to stabilize and grow the business.

Executive Chair Carrie Smith buys 65,400 shares of Organon (OGN) at $7.67 on 2025-11-12, increasing holdings 524.5% to 77,869 shares total.

Carrie Smith, Executive Chair of Organon, purchased 65,400 shares for $501,755.34 at $7.67, a substantial increase from her prior holdings of 12,469 shares. The transaction occurred as the stock trades at $7.62, down 53.6% from its 52-week high of $16.41 and down 20.3% over the prior 30 days. This marks Smith's second buy at Organon; her prior purchase on 2025-05-14 posted a 90-day return of +12.2%, establishing a pattern of well-timed entry at this ticker. The company's P/E of 3.95 paired with $160.0M in net income on $1.6B in quarterly revenue reflects a financially stable but structurally compressed valuation. The significant share accumulation, combined with her track record of profitable buys at this same ticker, suggests deliberate capital allocation during a period of substantial price weakness relative to recent highs.

Director Cox Smith buys 12,469 shares of OGN at $8.07; 5 other insiders also bought within 14 days amid 61.9% decline from 52-week high.

Director Carrie Smith purchased 12,469 shares at $8.07 on 2025-05-14, establishing a new position worth $100,591.16. This transaction occurs alongside a coordinated cluster pattern: 5 other insiders also bought OGN within the past 14 days. The timing occurs in a depressed price environment—OGN is trading $8.77, which is 61.9% below its 52-week high of $23.03, with a steep 90-day decline of 42.6%. The company trades at a low P/E of 3.03 with positive fundamentals including $1.5B in quarterly revenue and $87.0M net income (annual revenue growth of 2.2%). The coordinated buying pattern and founder-level purchasing into a severely drawdown stock warrant attention as a potential signal of conviction, though the actual motivation and forward intent cannot be inferred from transaction data alone.

Karp (EVP Corp. Dev.) purchases 3,500 shares of OGN at $8.24; stock down 62.0% from 52-week high as 5 insiders buy in 14 days

Daniel Karp, Executive VP of Corporate Development, purchased 3,500 shares at $8.24 on 2025-05-06, increasing his holdings to 46,669 shares. This transaction occurs within a cluster of 4 other insider purchases in the past 14 days, indicating coordinated or near-simultaneous buying activity. The stock has experienced severe weakness, trading at $8.76 current price against a 52-week high of $23.03 (-62.0%) and declining 30.0% over 30 days and 41.2% over 90 days. The confluence of accumulation by multiple insiders including a corporate development executive during a period of sharp valuation compression is noteworthy; investors should examine whether this reflects assessment of fundamental value at depressed levels or signals awareness of upcoming corporate developments related to Karp's portfolio responsibilities.

General Counsel Weaver Kirke bought 8,045 shares of OGN at $9.20 on 2025-05-06; stock now at $8.76, down 30.0% in 30 days, as cluster of 4 other insiders also bought within 14 days.

Weaver Kirke, General Counsel and Corporate Secretary, purchased 8,045 shares at $9.20, raising his holdings to 52,489 shares (+18.1% vs pre-transaction holdings). The transaction occurs amid a 30.0% 30-day decline and 41.2% 90-day decline from the 52-week high of $23.03, with the stock trading at $8.76 currently (-62.0% from peak). Notably, 4 other insiders also bought within the past 14 days, forming a cluster buy pattern. Kirke's prior open-market buy at OGN (2024-02-22) was well-timed at the 90-day mark, posting a +19.6% return, suggesting his historical transaction decisions have identified value inflection points. The P/E of 3.03 and quarterly revenue of $1.5B with $87.0M net income provide context for a modestly valued position, though the recent sharp price descent warrants observation of whether this coordinated insider activity signals conviction during distressed pricing or reflects routine portfolio activity.

CHRO Aaron Falcione buys 5,500 shares of OGN at $8.77; cluster of 4 insiders also bought in past 14 days amid -62.0% drawdown from 52-week high.

Aaron Falcione, Chief Human Resources Officer, purchased 5,500 shares at $8.77 on 2025-05-07 while OGN is trading at $8.76—materially below its 52-week high of $23.03 and down 30.0% over 30 days and 41.2% over 90 days. His post-transaction holdings increased to 62,973 shares from 57,473 shares, a +9.6% addition to his position. This transaction is part of a broader cluster pattern: 4 other insiders also bought within the past 14 days. While the company shows modest fundamentals with $1.5B revenue and P/E of 3.03, the synchronized purchasing activity by multiple insiders during an extended downturn warrants examination of whether this reflects informed confidence in recovery or reflects different motivations.

CEO Ali Kevin buys 34,000 OGN shares at $8.80; holdings rise to 282.7K shares as cluster buy emerges amid 60.4% decline from 52-week high

Ali Kevin, Chief Executive Officer, purchased 34,000 shares at $8.80 on 2025-05-05 for $299,370.00, increasing his holdings from 248.7K to 282.7K shares (a 13.7% addition to pre-transaction holdings). The purchase occurs in a broader pattern: 3 other insiders also bought within the past 14 days, establishing a cluster buy event. The timing is notable given the stock's trajectory: OGN currently trades at $9.13, representing a -60.4% decline from its 52-week high of $23.03 and a -30.0% drop over the past 30 days. Fundamentals show the company generated $1.5B in latest quarterly revenue, $87.0M in net income, with an annual revenue growth rate of +2.2% and a P/E of 3.16. The combination of CEO accumulation alongside peer buying activity, coupled with severe price weakness in a low-valuation environment, warrants investor attention to understand management's view of fair value relative to recent market action.

CFO Matthew M Walsh buys 11,400 shares of OGN at $8.82; 3 other insiders bought within 14 days as stock down -60.4% from 52-week high.

CFO Matthew M Walsh purchased 11,400 shares at $8.82 on 2025-05-05, increasing his holdings by 8.6% to 144,484 shares. The transaction occurred while OGN trades at $9.13, representing -60.4% from its 52-week high of $23.03 and down -30.0% over the past 30 days. Most significantly, this buy is part of a cluster pattern: 3 other insiders also purchased shares within the past 14 days. The company's P/E of 3.16 reflects a depressed valuation multiple relative to its $1.5B quarterly revenue base. The convergence of C-suite accumulation, multi-insider participation, and severe price deterioration creates a signal worth tracking—whether executives view current levels as a floor or whether further deterioration is possible.